Clinical Trial Update: Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of B244 in episodic migraine has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• B244

Snippet

Sponsor: AOBiome LLC | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2022-10-04